Blamey R W, Bennett R C, Singer A M, Nicol R, Harrison J
Br J Surg. 1975 Nov;62(11):863-7. doi: 10.1002/bjs.1800621103.
The uptake in vitro of 3H-thymidine and of 3H-uridine by white blood cells freshly taken from the recipients of renal transplants has been followed at regular intervals during the period of the patients' hospitalization. In addition, groups of subjects without renal failure undergoing operation and of patients on chronic dialysis have been studied. Of 33 patients undergoing rejection of their kidney, 28 showed a marked rise in the incorporation of thymidine over the period of rejection. However, a similar rise appears to accompany episodes of inter-current infection.
在肾移植受者住院期间,定期跟踪了刚从其体内采集的白细胞对³H-胸腺嘧啶核苷和³H-尿苷的体外摄取情况。此外,还对未患肾衰竭但接受手术的受试者组以及慢性透析患者进行了研究。在33例发生肾脏排斥反应的患者中,28例在排斥反应期间胸腺嘧啶核苷掺入量显著增加。然而,并发感染发作时似乎也会出现类似的增加。